Azimilide Hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAzimilide Hydrochloride
Drug Alias NameStedicor盐酸阿齐利特azimilida阿齐利特azimilide +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channel
Therapy Area/IndicationsGraft RejectionHeart FailureAtrial Fibrillation +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[15
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesForest Laboratories Inc
Active IndicationsN/A
Inactive IndicationsGraft RejectionHeart FailureAtrial Fibrillation +[6

Other Information

ATC CodeN/A